FMP

FMP

Enter

PTIX - Protagenic Therapeut...

photo-url-https://images.financialmodelingprep.com/symbol/PTIX.png

Protagenic Therapeutics, Inc.

PTIX

NASDAQ

Protagenic Therapeutics, Inc., a biopharmaceutical company, engages in the discovery and development of therapeutics to treat stress-related neuropsychiatric and mood disorders. Its lead compound is PT00114, a synthetic form of teneurin carboxy-terminal associated peptide, an endogenous brain signaling peptide that can dampen overactive stress responses. The company is based in New York, New York.

0.3 USD

0.0412 (13.73%)

PTIX Financial Statements

Quarter

2024 Q4

2024 Q3

2024 Q2

2024 Q1

Total Revenue

0

25.14k

0

0

Cost of Revenue

0

0

12.57k

12.57k

Gross Profit

0

25.14k

-12.57k

-12.57k

Operating Expenses

1.64M

652.07k

1.67M

1.73M

Research and Development

903.36k

364.18k

1.21M

1.46M

Selling, General & Administrative Expenses

739.82k

287.88k

453.3k

265.04k

Selling & Marketing Expenses

0

0

0

-12.57k

General & Administrative Expenses

739.82k

287.88k

453.3k

277.61k

Other Expenses

0

0

0

0

Operating Income

-1.64M

-652.07k

-1.67M

-1.74M

Total Other Income/Expenses Net

89.44k

11.28k

60.83k

14.06k

Income Before Tax

-1.55M

-640.78k

-1.61M

-1.72M

Income Tax

0

0

0

-2

Net Income

-1.55M

-640.78k

-1.61M

-1.72M

Basic EPS

-0.33

-0.14

-0.36

-0.39

EPS Diluted

-0.33

-0.14

-0.36

-0.39

Basic Average Shares

4.71M

4.53M

4.44M

4.44M

Diluted Average Shares

4.71M

4.53M

4.44M

4.44M

EBITDA

-1.54M

-639.49k

-1.59M

-1.71M

Retained Earning Schedule

Quarter

2024 Q4

2024 Q3

2024 Q2

2024 Q1

Retained Earnings (Previous Year)

-34.75M

-34.11M

-32.5M

-30.78M

Net Income

-1.55M

-640.78k

-1.61M

-1.72M

Stock Repurchases

0

0

0

0

Dividend Paid

0

0

0

0

Retained Earnings

-36.3M

-34.75M

-34.11M

-32.5M

Other Distributions

-1.55M

-640.78k

-1.61M

-1.72M

PPE Schedule

Quarter

2024 Q4

2024 Q3

2024 Q2

2024 Q1

Gross PPE

73.05k

85.62k

98.19k

110.76k

Annual Depreciation

12.57k

12.57k

12.57k

12.57k

Capital Expenditure

0

0

0

0

Net PPE

60.48k

73.05k

85.62k

98.19k

Intangible and Goodwill Schedule

Quarter

2024 Q4

2024 Q3

2024 Q2

2024 Q1

Acquisitions and Adjustments

0

0

0

0

Goodwill (Previous Year)

0

0

0

0

Goodwill

0

0

0

0

All figures are in USD.

FMP

FMP

Financial Modeling Prep API provides real time stock price, company financial statements, major index prices, stock historical data, forex real time rate and cryptocurrencies. Financial Modeling Prep stock price API is in real time, the company reports can be found in quarter or annual format, and goes back 30 years in history.
twitterlinkedin
2017-2025 © Financial Modeling Prep